Calamos Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.67M | Buy |
|
|||||
|
2025
Q2 | $1.39M | Sell |
|
|||||
|
2025
Q1 | $2.1M | Buy |
|
|||||
|
2024
Q4 | $1.54M | Sell |
|
|||||
|
2024
Q3 | $1.45M | Buy |
|
|||||
|
2024
Q2 | $914K | Buy |
|
|||||
|
2024
Q1 | $660K | Buy |
|
|||||
|
2023
Q4 | $328K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $910K | Sell |
|
|||||
|
2023
Q1 | $1.74M | Buy |
|
|||||
|
2022
Q4 | $1.06M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $208K | Hold |
|
|||||
|
2018
Q3 | $420K | Buy |
|